HK2 and non-small cell lung carcinoma: Targeting critical molecules implicated in glycolysis—namely glucose transporter 1 (GLUT1), hexokinase 2 (HK2), and lactate dehydrogenase A (LDHA)—can augment the radiosensitivity of NSCLC cells.